4 Topic Commentaries

Where AI is already paying off in drug development

• 

  Gaya Spolverato, MD

  Surgical oncology; clinical trial design

  •

  University Hospital of Padua / University of Padua

  AI is already reshaping our ability to design clinical trials, enabling more precise patient selection and more efficient study structures.

  Source
• 

  Regina Barzilay, PhD

  Artificial intelligence and computational drug discovery

  •

  Massachusetts Institute of Technology

  What we’re showing here is that AI can also provide mechanistic explanations, which are critical for moving a molecule through the development pipeline.

  Source
• 

  M. Khair ElZarrad, PhD, MPH

  Regulatory science and clinical trial policy

  •

  U.S. Food and Drug Administration

  AI has already been used in clinical research to improve medication adherence, actually.

  Source
• 

  Russ B. Altman, MD, PhD

  Biomedical informatics; pharmacogenomics; AI for drug discovery

  •

  Stanford University

  Indeed, we are already seeing it used by most pharmaceutical companies at different points in their discovery and development pipelines.

  Source